Tachycardia, Supraventricular D013617

Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Arrhythmias, Cardiac » Tachycardia » Tachycardia, Supraventricular

Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Cardiac Conduction System Disease » Tachycardia » Tachycardia, Supraventricular

Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Arrhythmias, Cardiac » Tachycardia » Tachycardia, Supraventricular

Description

A generic expression for any tachycardia that originates above the BUNDLE OF HIS.   MeSH

Approved Indicated Drugs (1)

Phase 3 Indicated Drugs (2)

Phase 2 Indicated Drugs (1)

Other Experimental Indicated Drugs (3)


Organization Involved with Phase 4 Indications (1)

Organization Involved with Phase 2 Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.